 | • レポートコード：MRC2Q12-19281 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、非オピオイド鎮痛薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 非オピオイド鎮痛薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 非オピオイド鎮痛薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 非オピオイド鎮痛薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの非オピオイド鎮痛薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の非オピオイド鎮痛薬の売上および2028年までの予測に焦点を当てています。 非オピオイド鎮痛薬のグローバル主要企業には、AbbVie Inc、Pfizer, Inc、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Centrexion Therapeutics、Cara Therapeutics、Medropharm GmbH.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 非オピオイド鎮痛薬市場は、タイプとアプリケーションによって区分されます。世界の非オピオイド鎮痛薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 NSAIDs、アセトアミノフェン、局所麻酔薬 【アプリケーション別セグメント】 病院薬局、小売店薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 非オピオイド鎮痛薬製品概要 - タイプ別市場（NSAIDs、アセトアミノフェン、局所麻酔薬） - アプリケーション別市場（病院薬局、小売店薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界の非オピオイド鎮痛薬販売量予測2017-2028 - 世界の非オピオイド鎮痛薬売上予測2017-2028 - 非オピオイド鎮痛薬の地域別販売量 - 非オピオイド鎮痛薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別非オピオイド鎮痛薬販売量 - 主要メーカー別非オピオイド鎮痛薬売上 - 主要メーカー別非オピオイド鎮痛薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（NSAIDs、アセトアミノフェン、局所麻酔薬） - 非オピオイド鎮痛薬のタイプ別販売量 - 非オピオイド鎮痛薬のタイプ別売上 - 非オピオイド鎮痛薬のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、オンライン薬局） - 非オピオイド鎮痛薬のアプリケーション別販売量 - 非オピオイド鎮痛薬のアプリケーション別売上 - 非オピオイド鎮痛薬のアプリケーション別価格 ・北米市場 - 北米の非オピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別の非オピオイド鎮痛薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの非オピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別の非オピオイド鎮痛薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の非オピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別の非オピオイド鎮痛薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の非オピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別の非オピオイド鎮痛薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの非オピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別の非オピオイド鎮痛薬市場規模（トルコ、サウジアラビア） ・企業情報 AbbVie Inc、Pfizer, Inc、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Centrexion Therapeutics、Cara Therapeutics、Medropharm GmbH. ・産業チェーン及び販売チャネル分析 - 非オピオイド鎮痛薬の産業チェーン分析 - 非オピオイド鎮痛薬の原材料 - 非オピオイド鎮痛薬の生産プロセス - 非オピオイド鎮痛薬の販売及びマーケティング - 非オピオイド鎮痛薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 非オピオイド鎮痛薬の産業動向 - 非オピオイド鎮痛薬のマーケットドライバー - 非オピオイド鎮痛薬の課題 - 非オピオイド鎮痛薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Non-opioid Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Non-opioid Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Non-opioid Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Non-opioid Analgesics include AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Centrexion Therapeutics, Cara Therapeutics and Medropharm GmbH., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Non-opioid Analgesics manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Non-opioid Analgesics market. Further, it explains the major drivers and regional dynamics of the global Non-opioid Analgesics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
AbbVie Inc
Pfizer, Inc
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Centrexion Therapeutics
Cara Therapeutics
Medropharm GmbH.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by distribution channel segments based on sales, price, and value for the period 2017-2028.
Non-opioid Analgesics Segment by Type
NSAIDs
Acetaminophen
Local Anesthetics
Non-opioid Analgesics Segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Non-opioid Analgesics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Non-opioid Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Non-opioid Analgesics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Non-opioid Analgesics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-opioid Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Non-opioid Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Non-opioid Analgesics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Centrexion Therapeutics, Cara Therapeutics and Medropharm GmbH., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Non-opioid Analgesics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Non-opioid Analgesics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by distribution channel and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by distribution channel and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by distribution channel and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by distribution channel and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by distribution channel and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-opioid Analgesics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Non-opioid Analgesics Product Introduction
1.2 Market by Type
1.2.1 Global Non-opioid Analgesics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NSAIDs
1.2.3 Acetaminophen
1.2.4 Local Anesthetics
1.3 Market by Distribution Channel
1.3.1 Global Non-opioid Analgesics Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-opioid Analgesics Sales Estimates and Forecasts 2017-2028
2.2 Global Non-opioid Analgesics Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-opioid Analgesics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-opioid Analgesics Sales by Region
2.4.1 Global Non-opioid Analgesics Sales by Region (2017-2022)
2.4.2 Global Sales Non-opioid Analgesics by Region (2023-2028)
2.5 Global Non-opioid Analgesics Revenue by Region
2.5.1 Global Non-opioid Analgesics Revenue by Region (2017-2022)
2.5.2 Global Non-opioid Analgesics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-opioid Analgesics Sales by Manufacturers
3.1.1 Global Top Non-opioid Analgesics Manufacturers by Sales (2017-2022)
3.1.2 Global Non-opioid Analgesics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-opioid Analgesics in 2021
3.2 Global Non-opioid Analgesics Revenue by Manufacturers
3.2.1 Global Non-opioid Analgesics Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-opioid Analgesics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-opioid Analgesics Revenue in 2021
3.3 Global Non-opioid Analgesics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-opioid Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-opioid Analgesics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-opioid Analgesics Sales by Type
4.1.1 Global Non-opioid Analgesics Historical Sales by Type (2017-2022)
4.1.2 Global Non-opioid Analgesics Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-opioid Analgesics Sales Market Share by Type (2017-2028)
4.2 Global Non-opioid Analgesics Revenue by Type
4.2.1 Global Non-opioid Analgesics Historical Revenue by Type (2017-2022)
4.2.2 Global Non-opioid Analgesics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
4.3 Global Non-opioid Analgesics Price by Type
4.3.1 Global Non-opioid Analgesics Price by Type (2017-2022)
4.3.2 Global Non-opioid Analgesics Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
5.1 Global Non-opioid Analgesics Sales by Distribution Channel
5.1.1 Global Non-opioid Analgesics Historical Sales by Distribution Channel (2017-2022)
5.1.2 Global Non-opioid Analgesics Forecasted Sales by Distribution Channel (2023-2028)
5.1.3 Global Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
5.2 Global Non-opioid Analgesics Revenue by Distribution Channel
5.2.1 Global Non-opioid Analgesics Historical Revenue by Distribution Channel (2017-2022)
5.2.2 Global Non-opioid Analgesics Forecasted Revenue by Distribution Channel (2023-2028)
5.2.3 Global Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
5.3 Global Non-opioid Analgesics Price by Distribution Channel
5.3.1 Global Non-opioid Analgesics Price by Distribution Channel (2017-2022)
5.3.2 Global Non-opioid Analgesics Price Forecast by Distribution Channel (2023-2028)
6 North America
6.1 North America Non-opioid Analgesics Market Size by Type
6.1.1 North America Non-opioid Analgesics Sales by Type (2017-2028)
6.1.2 North America Non-opioid Analgesics Revenue by Type (2017-2028)
6.2 North America Non-opioid Analgesics Market Size by Distribution Channel
6.2.1 North America Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
6.2.2 North America Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
6.3 North America Non-opioid Analgesics Market Size by Country
6.3.1 North America Non-opioid Analgesics Sales by Country (2017-2028)
6.3.2 North America Non-opioid Analgesics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Non-opioid Analgesics Market Size by Type
7.1.1 Europe Non-opioid Analgesics Sales by Type (2017-2028)
7.1.2 Europe Non-opioid Analgesics Revenue by Type (2017-2028)
7.2 Europe Non-opioid Analgesics Market Size by Distribution Channel
7.2.1 Europe Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
7.2.2 Europe Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
7.3 Europe Non-opioid Analgesics Market Size by Country
7.3.1 Europe Non-opioid Analgesics Sales by Country (2017-2028)
7.3.2 Europe Non-opioid Analgesics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-opioid Analgesics Market Size by Type
8.1.1 Asia Pacific Non-opioid Analgesics Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-opioid Analgesics Revenue by Type (2017-2028)
8.2 Asia Pacific Non-opioid Analgesics Market Size by Distribution Channel
8.2.1 Asia Pacific Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
8.2.2 Asia Pacific Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
8.3 Asia Pacific Non-opioid Analgesics Market Size by Region
8.3.1 Asia Pacific Non-opioid Analgesics Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-opioid Analgesics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Non-opioid Analgesics Market Size by Type
9.1.1 Latin America Non-opioid Analgesics Sales by Type (2017-2028)
9.1.2 Latin America Non-opioid Analgesics Revenue by Type (2017-2028)
9.2 Latin America Non-opioid Analgesics Market Size by Distribution Channel
9.2.1 Latin America Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
9.2.2 Latin America Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
9.3 Latin America Non-opioid Analgesics Market Size by Country
9.3.1 Latin America Non-opioid Analgesics Sales by Country (2017-2028)
9.3.2 Latin America Non-opioid Analgesics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-opioid Analgesics Market Size by Type
10.1.1 Middle East and Africa Non-opioid Analgesics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-opioid Analgesics Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-opioid Analgesics Market Size by Distribution Channel
10.2.1 Middle East and Africa Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
10.2.2 Middle East and Africa Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
10.3 Middle East and Africa Non-opioid Analgesics Market Size by Country
10.3.1 Middle East and Africa Non-opioid Analgesics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-opioid Analgesics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Overview
11.1.3 AbbVie Inc Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Inc Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Inc Recent Developments
11.2 Pfizer, Inc
11.2.1 Pfizer, Inc Corporation Information
11.2.2 Pfizer, Inc Overview
11.2.3 Pfizer, Inc Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer, Inc Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer, Inc Recent Developments
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.3.2 Teva Pharmaceutical Industries Ltd. Overview
11.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.4 Viatris Inc.
11.4.1 Viatris Inc. Corporation Information
11.4.2 Viatris Inc. Overview
11.4.3 Viatris Inc. Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Viatris Inc. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Inc. Recent Developments
11.5 Centrexion Therapeutics
11.5.1 Centrexion Therapeutics Corporation Information
11.5.2 Centrexion Therapeutics Overview
11.5.3 Centrexion Therapeutics Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Centrexion Therapeutics Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Centrexion Therapeutics Recent Developments
11.6 Cara Therapeutics
11.6.1 Cara Therapeutics Corporation Information
11.6.2 Cara Therapeutics Overview
11.6.3 Cara Therapeutics Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cara Therapeutics Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cara Therapeutics Recent Developments
11.7 Medropharm GmbH.
11.7.1 Medropharm GmbH. Corporation Information
11.7.2 Medropharm GmbH. Overview
11.7.3 Medropharm GmbH. Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medropharm GmbH. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medropharm GmbH. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-opioid Analgesics Industry Chain Analysis
12.2 Non-opioid Analgesics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-opioid Analgesics Production Mode & Process
12.4 Non-opioid Analgesics Sales and Marketing
12.4.1 Non-opioid Analgesics Sales Channels
12.4.2 Non-opioid Analgesics Distributors
12.5 Non-opioid Analgesics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-opioid Analgesics Industry Trends
13.2 Non-opioid Analgesics Market Drivers
13.3 Non-opioid Analgesics Market Challenges
13.4 Non-opioid Analgesics Market Restraints
14 Key Findings in The Global Non-opioid Analgesics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer